Drug Profile
Research programme: hydroxysteroid dehydrogenase inhibitors - Schering-Plough
Alternative Names: 11β-HSD1 inhibitors - Schering-PloughLatest Information Update: 30 Nov 2009
Price :
$50
*
At a glance
- Originator Schering-Plough
- Class
- Mechanism of Action 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued CNS disorders; Diabetes mellitus; Metabolic syndrome
Most Recent Events
- 07 Sep 2007 Preclinical trials in CNS disorders in USA (PO)
- 07 Sep 2007 Preclinical trials in Diabetes mellitus in USA (PO)
- 07 Sep 2007 Preclinical trials in Metabolic syndrome in USA (PO)